Get the Stockscreener App
0.7255
0.40%
0.0029
Xortx Therapeutics Inc stock is traded at $0.7255, with a volume of 177.34K.
It is up +0.40% in the last 24 hours and down -18.69% over the past month.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
See More
Previous Close:
$0.7226
Open:
$0.7226
24h Volume:
177.34K
Relative Volume:
1.79
Market Cap:
$2.75M
Revenue:
-
Net Income/Loss:
$-736.70K
P/E Ratio:
-72.55
EPS:
-0.01
Net Cash Flow:
$-4.14M
1W Performance:
-13.11%
1M Performance:
-18.69%
6M Performance:
-23.63%
1Y Performance:
-58.30%
1-Day Range:
$0.6608
$0.7499
1-Week Range:
$0.6608
$0.859
52-Week Range:
$0.6608
$2.9799
Xortx Therapeutics Inc Stock (XRTX) Company Profile
Compare XRTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XRTX
Xortx Therapeutics Inc
|
0.7255 | 3.65M | 0 | -736.70K | -4.14M | -0.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Xortx Therapeutics Inc Stock (XRTX) Latest News
What are the technical indicators suggesting about XORTX Therapeutics Inc.AI Powered Report For Fast Growth - jammulinksnews.com
XORTX Therapeutics Inc. stock chart pattern explainedMomentum Stocks with Breakout Potential - Newser
Will XORTX Therapeutics Inc. continue its uptrendFree Daily Top Performing Stock Insights - Newser
Combining price and volume data for XORTX Therapeutics Inc.Fast Entry Strategy with Price Prediction - Newser
What makes XORTX Therapeutics Inc. stock price move sharplyAI Model Forecasting Reversal and Breakout Zones - Newser
Trend analysis for XORTX Therapeutics Inc. this weekShort-Term Bounce Forecast for Oversold Stocks - Newser
Is XORTX Therapeutics Inc. stock poised for growthFree Confirmed Setup With Expert Accuracy - Newser
What is XORTX Therapeutics Inc. company’s growth strategyTop Growth Tips For Consistent Profits - jammulinksnews.com
What are the latest earnings results for XORTX Therapeutics Inc.Wealth Building Review That Work - jammulinksnews.com
Is XORTX Therapeutics Inc. stock overvalued or undervaluedAdvanced Screener Planner For 2025 - jammulinksnews.com
XORTX Announces USD $114,500 Private Placement - GlobeNewswire
XORTX Therapeutics Announces $114,500 Private Placement to Support Gout Programs - TipRanks
What momentum shifts mean for XORTX Therapeutics Inc.Short-Term AI-Based Stock Price Forecast - Newser
Is XORTX Therapeutics Inc. stock a growth or value playTechnical Long-Term Outlook and Recap Guide - Newser
Is this a good reentry point in XORTX Therapeutics Inc.ROI Focused Watchlist with Trade Confidence - Newser
How sentiment analysis helps forecast XORTX Therapeutics Inc.Free Weekly Setup With 3x Return Potential - Newser
New Product Launches: Will They Boost XORTX Therapeutics Inc. Stock in 2025Exit Ready Momentum Stock Watchlist Expanded - metal.it
What Fibonacci levels say about XORTX Therapeutics Inc. reboundCommunity Shared Smart Money Signals Show Movement - metal.it
Why XORTX Therapeutics Inc. stock attracts strong analyst attentionFree Growth Focused Entry Plan Suggestions - Newser
why xortx therapeutics inc. stock attracts strong analyst attentionLow Exposure Strategy with Sector Analysis - Newser
Published on: 2025-07-29 03:25:48 - Newser
What catalysts could drive XORTX Therapeutics Inc. stock higher in 2025Post Market Picks With Low Risk - jammulinksnews.com
Can XORTX Therapeutics Inc. Rally Enough to Break EvenRisk Adjusted Technical Entry Plan Gains Followers - metal.it
What are analysts’ price targets for XORTX Therapeutics Inc. in the next 12 monthsUnlock exclusive stock market insights - jammulinksnews.com
What is the dividend policy of XORTX Therapeutics Inc. stockCapitalize on proven investment strategies - jammulinksnews.com
XORTX Therapeutics Inc. stock retracement – recovery analysisBollinger Band Squeeze and Expansion Analysis - Newser
XORTX Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern Forming - Newser
Is XORTX Therapeutics Inc. a growth stock or a value stockMaximize your gains with expert trading tips - jammulinksnews.com
What momentum shifts mean for XORTX Therapeutics Inc. Free Fast Exit and Entry Strategy Guide - Newser
What is the risk reward ratio of investing in XORTX Therapeutics Inc. stockUnlock your trading potential today - jammulinksnews.com
Xortx Therapeutics Inc Stock (XRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):